Skip to main content
William Horton, MD, Endocrinology, Charlottesville, VA

William Benjamin Horton MD FACP

Diabetes, Lipid Metabolism, Osteoporosis & Bone Metabolism Medicine


Physician

Join to view full profile
  • 415 Ray C Hunt DrSte 2100Charlottesville, VA 22903

  • Phone+1 434-924-1825

  • Fax+1 434-244-9456

Dr. Horton is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. William Horton is an endocrinologist in Charlottesville, VA and is affiliated with multiple hospitals in the area, including University of Virginia Medical Center and University of Virginia Medical Center. He received his medical degree from University of Mississippi School of Medicine and has been in practice 7 years. He specializes in diabetes and lipid metabolism.

Education & Training

  • University of Mississippi Medical Center
    University of Mississippi Medical CenterResidency, Internal Medicine, 2013 - 2016
  • University of Mississippi School of Medicine
    University of Mississippi School of MedicineClass of 2013

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 2017 - 2028
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Endocrinology, Diabetes and Metabolism
    American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Clinical Trials

Publications & Presentations

PubMed

Authored Content

  • Adjunct Therapies to Insulin in People with Type 1 DiabetesJune 2025

Press Mentions

  • Weekend Catch-up Sleep May Harm Glucose Control
    Weekend Catch-up Sleep May Harm Glucose ControlApril 22nd, 2026

Grant Support

  • Development of a ketone-aware automated insulin delivery system to enable safe use of sodium-glucose cotransporter inhibitors in people with type 1 diabetesUNIVERSITY OF VIRGINIA2026–2029
  • Development of a ketone-aware automated insulin delivery system to enable safe use of sodium-glucose cotransporter inhibitors in people with type 1 diabetesUNIVERSITY OF VIRGINIA2026–2029
  • Development of a ketone-aware automated insulin delivery system to enable safe use of sodium-glucose cotransporter inhibitors in people with type 1 diabetesUNIVERSITY OF VIRGINIA2026–2029

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: